Introducing Tixel-i is a 2-minute treatment for Dry Eye Disease with no expression needed. Best in class results and longer lasting relief with proven safety. Tixel is the next generation of energy-based technology, built on over a decade of scientific and clinical innovation.
Thea Pharma, Inc
Thea Pharma Inc. is the U.S. subsidiary of Théa. Its product offering is comprised of a portfolio of seven leading eye-care products that are regulated or approved by the U.S. FDA, including Zioptan®, AcellFX™, Cosopt®, Cosopt® PF, Azasite®, Akten®, and Betimol®, iVIZIA dry-eye drops and eyelid hygiene products, and IYUZEH™. | Théa offers its technology and innovative preservative-free products to the US consumer under the iVIZIA brand of products—with iVIZIA lubricant eye drops as the foundation of the product line and formulated to cover the spectrum of dry eye relief. After its founding in 1994, Laboratories Théa was among the first eye care companies to introduce preservative-free products. Today, Laboratories Théa continues its pursuit of solutions that are more efficacious, more ergonomic, and safer.
iPothecary
iPothecary is a physician-guided platform that enables ophthalmology and optometry practices to recommend and deliver trusted eye care products directly to patients. By connecting patients with curated, doctor-recommended treatments, iPothecary helps practices extend care beyond the exam room, improve treatment adherence, and simplify access to professional-grade ocular therapies.
EyePromise (Formerly PRN Physician Recommended Nutriceuticals)
EyePromise is an eye health company created with a relentless commitment to science-backed eye health solutions dedicated to our shared passion for protecting the precious gift of sight.